Cannabis Clinical Trials

TEL AVIV Already a pioneer in high-tech and cutting-edge agriculture, Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home. Since 2014, U.S. firms have invested about $50 million in licensing Israeli medical marijuana patents, cannabis agro-tech startups and firms developing delivery devices such as inhalers, […]

by

When you think of cannabis and innovation, Israel likely doesn’t come to mind. But as we’ve recently highlighted here on MERRY JANE, Israel is advanced when it comes to cannabis-related exploration. Last week marked the second annual CannaTech conference, an international summit dedicated to accelerating cannabis innovation. The three-day event held in the capital city of Tel […]

by

With its moat, wall, barbed wire, armed guards and security cameras, the facility could be mistaken for a military base if it weren’t for the pungent odour of marijuana in the air.   Follow Ynetnews on Facebook and Twitter   Here, on the outskirts of a quiet village in northern Israel, 50,000 plants of 230 […]

by

by Paul Armentano, NORML Deputy Director March 22, 2016 Chronic pain patients with legal access to medicinal cannabis significantly decrease their use of opioids, according to data published online ahead of print in The Journal of Pain. Investigators at the University of Michigan, Ann Arbor conducted a retrospective survey of 244 chronic pain patients. All […]

by

Chronic pain patients with legal access to medicinal cannabis significantly decrease their use of opioids, according to data published online ahead of print in The Journal of Pain. Investigators at the University of Michigan, Ann Arbor conducted a retrospective survey of 244 chronic pain patients. All of the subjects in the survey were qualified under […]

by

A seemingly historic medical marijuana summit by several US government health agencies will largely exclude evidence coming from the states that have legalized medical cannabis — another example of entrenched Washington, DC bureaucrats placing politics over science in the marijuana debate. click to enlarge … read more at: http://www.eastbayexpress.com/LegalizationNation/archives/2016/03/22/historic-federal-summit-on-medicine-marijuana-is-slanted-by-drug-war-agenda

by

A marijuana-based drug has effectively treated children who suffer from a rare form of epilepsy known as Dravet syndrome in its first clinical trial, the drug’s manufacturer GW Pharmaceuticals announced on Monday. In a major victory for patients and legalization advocates, Epidiolex — a drug derived from a non-psychoactive component of marijuana known as cannabidiol […]

by

The big business of medical marijuana could soon get larger thanks to a clinical trial that has patients and investors very interested. Pharmaceutical company GW Pharma in a clinical trial was able to reduce convulsive seizures in children with the help of a marijuana-based drug. “It’s very positive,” Harborside General Manager Matt Smith said. “The […]

by

To save articles or get newsletters, alerts or recommendations – all free. Don’t have an account yet?Create an account » Subscribed through iTunes and need an NYTimes.com account?Learn more » … read more at: http://www.nytimes.com/2016/03/15/business/marijuana-based-drug-found-to-reduce-epileptic-seizures.html

by

Jerusalem — Six months of Palestinian terror attacks didn’t discourage scores of medical cannabis experts and investors from flocking to Israel last week for a medical cannabis (marijuana) conference. Israel’s 2nd CannaTech conference, which focused on “accelerating cannabis innovation,” attracted participants from dozens of countries eager to capitalize on the country’s research and know-how, as […]

by